Manufacturing-focused emissions reductions in footwear production

What is the burden upon your feet? With sales of running and jogging shoes in the world averaging a nontrivial 25 billion shoes per year, or 34 million per day, the impact of the footwear industry represents a significant portion of the apparel sector's environmental burden. A single shoe can contain 65 discrete parts that require 360 processing steps for assembly. While brand name companies dictate product design and material specifications, the actual manufacturing of footwear is typically contracted to manufacturers based in emerging economies. Using life cycle assessment methodology in accordance with the ISO 14040/14044 standards, this effort quantifies the life cycle greenhouse gas emissions, often referred to as a carbon footprint, of a pair of running shoes. Furthermore, mitigation strategies are proposed focusing on high leverage aspects of the life cycle. Using this approach, it is estimated that the carbon footprint of a typical pair of running shoes made of synthetic materials is 14 ± 2.7 kg CO[subscript 2]-equivalent. The vast majority of this impact is incurred during the materials processing and manufacturing stages, which make up around 29% and 68% of the total impact, respectively. Other similar studies in the apparel industry have reported carbon footprints of running shoes ranging between 18 and 41 kg CO[subscript 2]-equivalent/pair (PUMA, 2008; Timberland, 2009). For consumer products not requiring electricity during use, the intensity of emissions in the manufacturing phase is atypical; most commonly, materials make up the biggest percentage of impact. This distinction highlights the importance of identifying mitigation strategies within the manufacturing process, and the need to evaluate the emissions reduction efficacy of each potential strategy. By suggesting a few of the causes of manufacturing dominance in the global warming potential assessment of this product, this study hypothesizes the characteristics of a product that could lead to high manufacturing impact. Some of these characteristics include the source of energy in manufacturing and the form of manufacturing, in other words the complexity of processes used and the area over which these process are performed (particularly when a product involves numerous parts and light materials). Thereby, the work provides an example when relying solely on the bill of materials information for product greenhouse gas emissions assessment may underestimate life cycle burden and ignore potentially high impact mitigation strategies

Un blog: una experiencia cooperativa, solidaria y transformadora

EBLOG EGCI es el producto de la cooperación entre profesionales que se desempeñan en áreas gubernamentales y no gubernamentales de tres provincias argentinas (Córdoba, Entre Ríos y Santa Fe) y que -sin fines de lucro- socializan, difunden y generan documentos y piezas de comunicación en diversos formatos sobre gerontología y adultos mayores atendiendo la interdisciplinariedad y las particularidades de los regionalismos y localismos que se plantean en un marco federal. El BLOG EGCI nace como necesidad de contacto y socialización de materiales, vivencias e información en gerontología de especializandos de la Carrera de Posgrado de Gerontología Comunitaria e Institucional, como experiencia federal a lo largo y ancho de Argentina, donde los profesionales de diversas carreras de grado fueron seleccionados para participar de dicha experiencia. La misma comenzó en 2008 y finalizó su cursado en 2010. El desarrollo de esta experiencia ha supuesto la conformación y organización de una red virtual de trabajo y comunicación que posibilita el funcionamiento y la sustentabilidad de la propuesta comunicativa

Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.

Andersen-Tawil Syndrome type 1 (ATS1) is a rare arrhythmogenic disorder, caused by loss-of-function mutations in the KCNJ2 gene. We present here the largest cohort of patients with ATS1 with outcome data reported. This study sought to define the risk of life-threatening arrhythmic events (LAE), identify predictors of such events, and define the efficacy of antiarrhythmic therapy in patients with ATS1. Clinical and genetic data from consecutive patients with ATS1 from 23 centers were entered in a database implemented at ICS Maugeri in Pavia, Italy, and pooled for analysis. We enrolled 118 patients with ATS1 from 57 families (age 23 ± 17 years at enrollment). Over a median follow-up of 6.2 years (interquartile range: 2.7 to 16.5 years), 17 patients experienced a first LAE, with a cumulative probability of 7.9% at 5 years. An increased risk of LAE was associated with a history of syncope (hazard ratio [HR]: 4.54; p = 0.02), with the documentation of sustained ventricular tachycardia (HR 9.34; p = 0.001) and with the administration of amiodarone (HR: 268; p  Our data demonstrate that the clinical course of patients with ATS1 is characterized by a high rate of LAE. A history of unexplained syncope or of documented sustained ventricular tachycardia is associated with a higher risk of LAE. Amiodarone is proarrhythmic and should be avoided in patients with ATS1